Using Gene Editing Approaches to Fine-Tune the Immune System

Area of Science:

• Immunology
• Molecular Biology
• Biotechnology

Background:

• Genome editing offers powerful tools for understanding cellular functions and advancing clinical treatments.
• Fine-tuning the immune system is crucial for developing novel therapeutic strategies.

Purpose of the Study:

• To review gene editing techniques for immune system modulation from both basic research and clinical viewpoints.
• To discuss advancements in programmable nucleases and their application in immune cell engineering.
• To explore innovations in genome surgery for cancer immunotherapy.

Main Methods:

• Analysis of programmable nucleases: zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and CRISPR-Cas nucleases.
• Discussion of base editing tools for gene disruption, insertion, and rewriting in immune cells (T cells, NKs, HSPCs).
• Examination of gene editing strategies for chimeric antigen receptor (CAR) T-cell therapy, including allogeneic transplantation and transgene delivery to endogenous loci.

Main Results:

• Gene editing enables precise engineering of immune cells for therapeutic applications.
• Programmable nucleases and base editors facilitate targeted modifications of immune components.
• CRISPR and related technologies enhance CAR T-cell therapy by enabling allogeneic approaches, reducing costs, and improving treatment accessibility.
• Targeted delivery of therapeutic transgenes to endogenous loci increases effectiveness and minimizes collateral damage.

Conclusions:

• Genome editing technologies are revolutionizing immune system research and clinical applications.
• Innovations in gene editing, including immune system repurposing, are paving the way for safer and more efficient cancer immunotherapies.
• The precise control over immune cell function through genome surgery holds significant promise for future therapeutic interventions.